Targeting Signaling Pathways in Inflammatory Breast Cancer

by Xiaoping Wang, Takashi Semba, Lan Thi Hanh Phi, Sudpreeda Chainitikun, Toshiaki Iwase, Bora Lim, Naoto T. Ueno
Published 2020-09-01

Changes in Overall Survival over Time for Patients with de novo Metastatic Breast Cancer

by Toshiaki Iwase, Tushaar Vishal Shrimanker, Ruben Rodriguez-Bautista, Onur Sahin, Anjali James, Jimin Wu, Yu Shen, Naoto T. Ueno
Published 2021-05-01

Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines

by Xuemei Xie, Jangsoon Lee, Jon A. Fuson, Huey Liu, Toshiaki Iwase, Kyuson Yun, Cori Margain, Debu Tripathy, Naoto T. Ueno
Published 2023-02-01

PI3K and MAPK Pathways as Targets for Combination with the Pan-HER Irreversible Inhibitor Neratinib in HER2-Positive Breast Cancer and TNBC by Kinome RNAi Screening

by Jangsoon Lee, Huey Liu, Troy Pearson, Toshiaki Iwase, Jon Fuson, Alshad S. Lalani, Lisa D. Eli, Irmina Diala, Debu Tripathy, Bora Lim, Naoto T. Ueno
Published 2021-06-01

Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: A systematic review.

by Sudpreeda Chainitikun, Jose Rodrigo Espinosa Fernandez, James P Long, Toshiaki Iwase, Kumiko Kida, Xiaoping Wang, Sadia Saleem, Bora Lim, Vicente Valero, Naoto T Ueno
Published 2021-01-01

Validation of Prognostic Stage and Anatomic Stage in the American Joint Committee on Cancer 8th Edition for Inflammatory Breast Cancer

by Kumiko Kida, Kenneth R. Hess, Bora Lim, Toshiaki Iwase, Sudpreeda Chainitikun, Vicente Valero, Anthony Lucci, Huong Carisa Le-Petross, Wendy A. Woodward, Savitri Krishnamurthy, Gabriel N. Hortobagyi, Debu Tripathy, Naoto T. Ueno
Published 2020-10-01

The Prognostic Impact of Body Composition for Locally Advanced Breast Cancer Patients Who Received Neoadjuvant Chemotherapy

by Toshiaki Iwase, Aaroh Parikh, Seyedeh S. Dibaj, Yu Shen, Tushaar Vishal Shrimanker, Sudpreeda Chainitikun, Kumiko Kida, Maryanne E. Sapon, Onur Sahin, Anjali James, Andrea Yizel Delgado Medrano, Ann H. Klopp, Naoto T. Ueno
Published 2021-02-01

A Novel Immunomodulatory 27-Gene Signature to Predict Response to Neoadjuvant Immunochemotherapy for Primary Triple-Negative Breast Cancer

by Toshiaki Iwase, Kim R. M. Blenman, Xiaotong Li, Emily Reisenbichler, Robert Seitz, David Hout, Tyler J. Nielsen, Brock L. Schweitzer, Daniel B. Bailey, Yichao Shen, Xiang Zhang, Lajos Pusztai, Naoto T. Ueno
Published 2021-09-01

Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC

by Toshiaki Iwase, Kenichi Harano, Hiroko Masuda, Kumiko Kida, Kenneth R. Hess, Ying Wang, Luc Dirix, Steven J. Van Laere, Anthony Lucci, Savitri Krishnamurthy, Wendy A. Woodward, Rachel M. Layman, François Bertucci, Naoto T. Ueno
Published 2020-05-01

Phase II study of Radium‐223 dichloride combined with hormonal therapy for hormone receptor‐positive, bone‐dominant metastatic breast cancer

by Naoto T. Ueno, Rie K. Tahara, Takeo Fujii, James M. Reuben, Hui Gao, Babita Saigal, Anthony Lucci, Toshiaki Iwase, Nuhad K. Ibrahim, Senthil Damodaran, Yu Shen, Diane D. Liu, Gabriel N. Hortobagyi, Debu Tripathy, Bora Lim, Beth A. Chasen
Published 2020-02-01